In the two previous posts about the recent CME rules put out by ACCME:
--I included references to the very angry reactions to the ACCME ruling from both NIH and the American Heart Association. Thanks to loyal reader Marilyn Mann, I can now report that the AHA's anger at least seems to have been effective:
In short, first ACCME first said that scientists who are paid full-time by industry cannot give CME talks, for credit, about their company's products. (I mistakenly said at first they could not give any talks at all, which seemed way unreasonable, and then corrected that misimpression.) That led the leadership of AHA to have a hissy fit. That led ACCME to change its mind and restore the CME credits they had been prepared to strip from the AHA's planned fall conference. The reason given was that somehow AHA had persuaded ACCME that their internal controls over speaker bias were sufficiently strict to be sure that no one says anything out of line. Marilyn asked me how to explain this as the ACCME decision making process seemed pretty opaque to her. I said, join the club.
My pals who follow this more closely than I, as well as numerous previous news accounts, consider AHA one of the most-in-bed-with-industry medical organizations, well known for accepting huge sums and for filling their guideline panels with conflicted folks.